Skip to content

Clinical trials

Phase 2/3 Carcinoma, Hepatocellular trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Hepatocellular Phase: Phase 2/3 Country / region: China Clear all

33 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20071
20083
20092
20131
20141
20151
20181
20196
20201
20214
20225
20231
20241
20252
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status14
Recruiting7
Completed4
Terminated3
Not yet recruiting2
Active, not recruiting2
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eastern Hepatobiliary Surgery Hospital4
Fudan University2
Guangxi Medical University2
Shanghai Zhongshan Hospital2
Sun Yat-sen University2
Zhongda Hospital2
Chinese PLA General Hospital1
Innovent Biologics (Suzhou) Co. Ltd.1
Innovent Biopharmaceutical Technology (Hangzhou) Co., LTD.1
Mian XI1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Hepatocellular33
Liver Neoplasms4
Adenocarcinoma1
Bites and Stings1
Breast Neoplasms1
Colonic Neoplasms1
Digestive System Diseases1
Digestive System Neoplasms1
Gastrointestinal Neoplasms1
Head and Neck Neoplasms1

Trials

Showing 1 to 25 of 33. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.